What does it need to take to avoid developing “wrong" Medical Technology products/services?
Healthcare will change dramatically in the next 20 years with the emergence of artificial intelligence (including machine and deep learning), 3D printing, personalised diagnosis and therapies, shift from therapy to prevention, and many related delivery and economic changes. Huge opportunities are present in emerging and developing nations ... with completely different needs and infrastructural environments than we are used to have in Europe or the US … these also could be examples for reverse innovation. The talk will present the product and technology approach and some recent examples of the chair of catheter technologies and image guided therapies that focusses on joint product developments between clinicians and engineers leading to the question of what are good versus bad value propositions for Medical Technology Products?
.
Date and Time
Location
Hosts
Registration
- Date: 30 Jan 2018
- Time: 06:00 PM UTC to 07:00 PM UTC
-
Add Event to Calendar
- University of Dubai
- dubai, United Arab Emirates
- United Arab Emirates 14143
- Building: Engineering
- Room Number: 103
- Contact Event Host
- Co-sponsored by University of Dubai
- Starts 26 January 2018 11:58 AM UTC
- Ends 30 January 2018 05:58 PM UTC
- No Admission Charge
Speakers
Prof. Michael Friebe
What does it need to take to avoid developing “wrong" Medical Technology products/services?
Healthcare will change dramatically in the next 20 years with the emergence of artificial intelligence (including machine and deep learning), 3D printing, personalised diagnosis and therapies, shift from therapy to prevention, and many related delivery and economic changes. Huge opportunities are present in emerging and developing nations ... with completely different needs and infrastructural environments than we are used to have in Europe or the US … these also could be examples for reverse innovation. The talk will present the product and technology approach and some recent examples of the chair of catheter technologies and image guided therapies that focusses on joint product developments between clinicians and engineers leading to the question of what are good versus bad value propositions for Medical Technology Products?
.
Healthcare will change dramatically in the next 20 years with the emergence of artificial intelligence (including machine and deep learning), 3D printing, personalised diagnosis and therapies, shift from therapy to prevention, and many related delivery and economic changes. Huge opportunities are present in emerging and developing nations ... with completely different needs and infrastructural environments than we are used to have in Europe or the US … these also could be examples for reverse innovation. The talk will present the product and technology approach and some recent examples of the chair of catheter technologies and image guided therapies that focusses on joint product developments between clinicians and engineers leading to the question of what are good versus bad value propositions for Medical Technology Products?
.
Biography:
Prof. Michael Friebe, PhD: Michael Friebe’s expertise is in diagnostic imaging + image guided therapies, as founder/innovator/CEO/investor, and scientist. After a BSc. in electrical eng. he spend 5 years in San Francisco as R&D Engineer at a MRI and Ultrasound device manufacturer. In that time he graduated with a MSc. in Technology Management from Golden Gate University, San Francisco. Back in Germany he started his first company (Mobile MRI) and worked in parallel on his PhD in Medical Physics (University Witten, Germany, 1995). He has started more than 15 companies, 5 as major shareholder/CEO. He is very enthusiastic about teaching innovation generation and MedTec entrepreneurship. Dr. Friebe currently is a research fellow of TUM, Munich and a professor of Image Guided Therapies at Otto-von-Guericke-University in Magdeburg, Germany, listed inventor of more than 80 patents, author of >150 papers, board member of four medical technology startup companies, and an investment partner of a MedTec investment-fund. Since 2016 he is also a Distinguished Lecturer of the IEEE EMBS.